T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata

British Journal of Dermatology

Volumn 169, Issue 3, 2013, Pages 543-548

  Tembhre, M K ^a   Sharma, V K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALOPECIA AREATA; ARTICLE; ATOPY; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ADULT; ALOPECIA AREATA; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84880580415     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12396     Document Type: Article

References (42)

1. Afzali B, Lombardi G, Lechler RI, Lord GM,. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46.
2. Furuzawa-Carlalleda J, Vargas-Rojas MI, Cabral AR,. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007; 6: 169-75.
3. Weaver CT, Harrington LE, Mangan PR, et al,. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677-88.
4. Kalish RS, Gilhar A,. Alopecia areata: autoimmunity-the evidence is compelling. J Investig Dermatol Symp Proc 2003; 8: 164-7.
5. Ito T, Meyer KC, Ito N, Paus R,. Immune privilege and the skin. Curr Dir Autoimmun 2008; 10: 27-52.
6. King LE Jr, McElwee KJ, Sundberg JP,. Alopecia areata. Curr Dir Autoimmun 2008; 10: 280-312.
7. Petukhova L, Duvic M, Hordinsky M, et al,. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010; 466: 113-17.
8. O'Garra A, Vieira P,. Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10: 801-5.
9. Taylor A, Verhagen J, Blaser K, et al,. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 2006; 117: 433-42.
10. Levings MK, Bacchetta R, Schulz U, Roncarolo MG,. The role of IL-10 and TGF-β in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol 2002; 129: 263-76.
11. Hoffmann R, Wenzel E, Huth A, et al,. Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994; 103: 530-3.
12. Teraki Y, Imanishi K, Shiohara T,. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Derm Venereol 1996; 76: 421-3.
13. Bodemer C, Peuchmaur M, Fraitaig S, et al,. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 2000; 114: 112-16.
14. McElwee KJ, Hoffmann R,. Alopecia areata-animal models. Clin Exp Dermatol 2002; 27: 410-17.
15. Arca E, Musabak U, Akar A, et al,. Interferon-gamma in alopecia areata. Eur J Dermatol 2004; 14: 33-6.
16. Katagiri K, Arakawa S, Hatano Y,. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis. Arch Dermatol Res 2007; 298: 397-401.
17. Cantrell DA, Smith KA,. The interleukin-2 T-cell system: a new cell growth model. Science 1984; 224: 1312-16.
18. Malek TR,. The biology of interleukin-2. Annu Rev Immunol 2008; 26: 453-79.
19. Valsecchi R, Imberti G, Martino D, Cainelli T,. Alopecia areata and interleukin-2 receptor. Dermatology 1992; 184: 126-8.
20. Barahmani N, Lopez A, Babu D, et al,. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Clin Exp Dermatol 2010; 35: 409-16.
21. Sato-Kawamura M, Aiba S, Tagami H,. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Arch Dermatol Res 2003; 12: 536-43.
22. Alli R, Nguyen P, Boyd K, et al,. A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. J Immunol 2012; 188: 477-86.
23. Letada PR, Sparling JD, Norwood C,. Imiquimod in the treatment of alopecia universalis. Cutis 2007; 79: 138-40.
24. Tang L, Cao L, Pelech S, et al,. Cytokines and signal transduction pathways mediated by anthralin in alopecia areata-affected Dundee experimental balding rats. J Investig Dermatol Symp Proc 2003; 8: 87-90.
25. Freyschmidt-Paul P, McElwee KJ, Happle R, et al,. Interleukin-10- deficient mice are less susceptible to the induction of alopecia areata. J Invest Dermatol 2002; 119: 980-2.
26. Jagielska D, Redler S, Brockschmidt FF, et al,. Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance. J Invest Dermatol 2012; 132: 2192-7.
27. Stowe RP, Peek MK, Cutchin MP, Goodwin JS,. Plasma cytokine levels in a population-based study: relation to age and ethnicity. J Gerontol A Biol Sci Med Sci 2010; 65: 429-33.
28. Cua DJ, Sherlock J, Chen Y, et al,. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-8.
29. Langrish CL, Chen Y, Blumenschein WM, et al,. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-40.
30. Korn T, Bettelli E, Oukka M, Kuchroo VK,. IL-17 and Th17 cells. Annu Rev Immunol 2009; 27: 485-517.
31. Oukka M, Th17 cells in immunity and autoimmunity. Ann Rheum Dis 2008; 67 (Suppl. 3):iii 26-9.
32. Zhang L, Yuan S, Cheng G, Guo B,. Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS ONE 2011; 6: e28432.
33. Ochs HD, Gambineri E, Torgerson TR,. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 2007; 38: 112-21.
34. Brunkow ME, Jeffery EW, Hjerrild KA, et al,. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27: 68-73.
35. Sakaguchi S, Ono M, Setoguchi R, et al,. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8-27.
36. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA,. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-53.
37. Stephens LA, Mottet C, Mason D, Powrie F,. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001; 31: 1247-54.
38. Taams LS, Vukmanovic-Stejic M, Smith J, et al,. Antigen-specific T cell suppression by human CD4+ CD25+ regulatory T cells. Eur J Immunol 2002; 32: 1621-30.
39. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN,. Regulatory T cells and human disease. Clin Dev Immunol 2007; 2007: 89195.
40. Groux H, Bigler M, de Vries JE, Roncarolo MG,. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996; 184: 19-29.
41. Paus R, Ito N, Takigawa M, Ito T,. The hair follicle and immune privilege. J Investig Dermatol Symp Proc 2003; 8: 188-94.
42. Becker JC, Varki N, Bröcker EB, Reisfeld RA,. Lymphocyte-mediated alopecia in C57BL/6 mice following successful immunotherapy for melanoma. J Invest Dermatol 1996; 107: 627-32.